Advancing Novel Cell Therapy for Myeloma and Multiple Cancers Goal of New Partnership
A recent partnership between Indapta Therapeutics and Lonza is…
Myeloma
Myeloma overview
Myeloma is a rare blood cancer that begins in plasma cells, a type of white blood cell normally responsible for producing antibodies that help fight off infectious pathogens and other threats.
Read moreMyeloma treatment
While myeloma treatment can drive the disease into remission, sometimes for long periods of time, the cancer will often come back after a few months or years, and additional treatments will be needed.
Read moreLatest news
EMA Reviewing Belantamab Mafodotin for Heavily Pretreated Multiple Myeloma
The European Medicines Agency has agreed to review…
Takeda, Snow Myeloma App ‘Being Patient’ Wins Pharma Choice Award
Takeda and Snow Companies won one of…
Researchers Provide Highlights on Study into Benefits of Reolysin, Kyprolis Combo in Multiple Myeloma
Researchers are continuing to study how the combination…
Allogene, SpringWorks Collaborate to Test ALLO-715, Nirogacestat Combo for RRMM
Allogene Therapeutics and…
Sanofi Partners to Develop Diagnostic Test for Multiple Myeloma Patients on Potential Therapy
Sanofi announced that it partnered with Sebia to develop a…
